The enduring success of sildenafil has undeniably transformed the drug landscape. However, putting money in companies heavily reliant on biosimilars and the waning patent rights surrounding this flagship https://tiannahspw138961.fireblogz.com/72537310/the-blue-pill-and-drugmakers-a-risky-opportunity